Capital Impact Advisors LLC raised its holdings in Select Medical Holdings Co. (NYSE:SEM – Get Rating) by 10.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 33,474 shares of the health services provider’s stock after acquiring an additional 3,153 shares during the quarter. Select Medical accounts for about 0.8% of Capital Impact Advisors LLC’s holdings, making the stock its 27th biggest position. Capital Impact Advisors LLC’s holdings in Select Medical were worth $791,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently bought and sold shares of SEM. BlackRock Inc. raised its stake in shares of Select Medical by 4.3% during the 1st quarter. BlackRock Inc. now owns 18,575,139 shares of the health services provider’s stock worth $445,617,000 after buying an additional 762,219 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of Select Medical by 46.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 2,131,042 shares of the health services provider’s stock worth $47,097,000 after buying an additional 676,592 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Select Medical by 1.8% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 23,011,826 shares of the health services provider’s stock worth $543,539,000 after buying an additional 396,618 shares during the last quarter. State Street Corp raised its stake in shares of Select Medical by 7.0% during the 1st quarter. State Street Corp now owns 4,079,467 shares of the health services provider’s stock worth $97,866,000 after buying an additional 266,914 shares during the last quarter. Finally, Great West Life Assurance Co. Can acquired a new position in shares of Select Medical during the 3rd quarter worth $2,582,000. Institutional investors and hedge funds own 78.75% of the company’s stock.
Select Medical Stock Up 2.7 %
SEM opened at $25.73 on Friday. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.10 and a quick ratio of 1.10. The stock has a market capitalization of $3.27 billion, a price-to-earnings ratio of 20.92, a price-to-earnings-growth ratio of 0.83 and a beta of 1.40. The business has a 50-day moving average of $27.98 and a two-hundred day moving average of $25.58. Select Medical Holdings Co. has a 12 month low of $18.86 and a 12 month high of $30.78.
Select Medical Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 15th. Shareholders of record on Friday, March 3rd were issued a $0.125 dividend. This represents a $0.50 annualized dividend and a yield of 1.94%. The ex-dividend date of this dividend was Thursday, March 2nd. Select Medical’s dividend payout ratio (DPR) is 40.65%.
Insider Transactions at Select Medical
In other news, CEO David S. Chernow sold 139,550 shares of the business’s stock in a transaction dated Monday, February 27th. The stock was sold at an average price of $27.30, for a total transaction of $3,809,715.00. Following the completion of the sale, the chief executive officer now owns 839,550 shares in the company, valued at approximately $22,919,715. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 19.14% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on SEM. StockNews.com began coverage on Select Medical in a research report on Thursday. They set a “hold” rating for the company. Credit Suisse Group lifted their price objective on Select Medical from $24.00 to $29.00 and gave the stock a “neutral” rating in a research report on Monday, February 27th. Finally, Benchmark reiterated a “buy” rating and set a $39.00 price objective on shares of Select Medical in a research report on Monday, February 27th. Two equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $33.75.
Select Medical Company Profile
Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility.
- Get a free copy of the StockNews.com research report on Select Medical (SEM)
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.